Interventional procedures for cancer pain management: When are they indicated?

Cancer Investigation

Volumn 22, Issue 4, 2004, Pages 630-642

  De Leon Casasola, Oscar A ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; LIDOCAINE; LOCAL ANESTHETIC AGENT; LOPERAMIDE; METHYLPREDNISOLONE ACETATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA CONOTOXIN MVIIA; OPIATE; PHENOL; SUFENTANIL;

CANCER PAIN; CATHETER; DIARRHEA; GRANULOMA; HUMAN; INFUSION PUMP; NAUSEA; NEUROLYSIS; ORTHOSTATIC HYPOTENSION; PARAPLEGIA; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; REVIEW; TITRIMETRY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VOMITING;

ANALGESICS; DRUG THERAPY, COMBINATION; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; NEOPLASMS; NERVE BLOCK; PAIN MEASUREMENT; PAIN, INTRACTABLE;

EID: 8644244551     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-200027166     Document Type: Review

References (64)

1. Jacox, A.; Carr, D.B.; Payne, R. Management of Cancer Pain, Clinical Practice Guidelines; U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research: Rockville, MD, 1994, No. 9, AHCPR publication No. 94-0592.
2. Portenoy, R. Managing pain in patients with advanced cancer: the role of neuroaxial infusion. Oncology 1999, 13 (Supplement No. 2), 7-8.
3. Bennett, G.; Burchiel, K.; Buchser, E.; et al. Clinical guidelines for intraspinal infusion: report of an expert panel. J. Pain Symptom Manage. 2000, 20, S37-S43.
4. Crul, B.J.; Delhaas, E. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients. Reg. Anesth. 1991, 16, 209-213.
5. De Leon-Casasola, O.A.; Lema, M.J. Technique for thoracic epidural insertion and subcutaneous catheter tunneling. ASRA Conf. Resume Book 1992, 187.
6. Appelgreen, L.; Janson, M.; Nitescu, P.; et al. Continuous intracisternal and high cervical intrathecal infusion of bupivacaine in refractory head and neck pain. Anesthesiology 1996, 84, 256-272.
7. Nitescu, P.; Sjoberg, M.; Appelgren, L.; et al. Complications of intrathecal opioids and bupivacaine in the treatment of "refractory" cancer pain. Clin. J. Pain 1995, 11, 45-62.
8. Bevacqua, B.K.; Slucky, A.V.; Cleary, W.F. Is postoperative intrathecal catheter use associated with central nervous system infection? Anesthesiology 1994, 80, 1234-1240.
9. Van Dongen, R.T.M.; Crul, B.J.P.; DeBock, M. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. Pain 1993, 55, 119-123.
10. Plummer, J.L.; Cherry, D.A.; Cousins, M.K.; et al. Long-term spinal administration of morphine in cancer and non-cancer pain: a retrospective study. Pain 1991, 44, 215-220.
11. De Jong, P.C.; Kansen, P.J. A comparison of epidural catheters with or without subcutaneous injection ports for treatment of cancer pain. Anesth. Analg. 1994, 78, 94-100.
12. DuPen, S.L.; Peterson, D.G.; Bogosian, A.; et al. A new permanent exteriorized epidural catheter for narcotic self-administration to control cancer pain. Cancer 1987, 59, 986-993.
13. Bedder, M.D.; Burchiel, K.; Larson, A. Cost analysis of two implantable narcotic delivery systems. J. Pain Symptom Manage. 1991, 6, 368-373.
14. DuPen, S.L.; Peterson, D.G.; Williams, A.; et al. Infection during chronic epidural catheterization: diagnosis and treatment. Anesthesiology 1990, 73, 905-909.
15. Rauck, R.; Southern, J.; Speight, K.; et al. Use of a new model infusion system for intrathecal delivery of morphine sulfate. Anesthesiology 1998, 89 (S), 1082.
16. Penn, R.D.; Paice, J.A. Chronic intrathecal morphine for intractable pain. J. Neurosurg. 1987, 67, 182-186.
17. Paice, J.A.; Penn, R.D.; Shott, S. Intraspinal morphine for chronic pain: a retrospective multicenter study. J. Pain Symptom Manage. 1996, 11, 71-80.
18. Hassenbusch, S.J.; Paice, J.A.; Patt, R.B.; Bedder, M.D.; Bell, G.K. Clinical realities and economic considerations: economics of intrathecal therapy. J. Pain Symptom Manage. 1997, 3 (Suppl.), S36-S48.
19. Nitescu, P.; Appelgren, L.; Linder, L.E.; et al. Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatment in advanced cancer pain. J. Pain Symptom Manage. 1990, 5, 18-26.
20. Appelgren, L.; Nordborg, C.; Sjoberg, M.; et al. Spinal epidural metastasis: implications for spinal analgesia to treat "refractory" cancer pain. J. Pain Symptom Manage. 1997, 13, 25-42.
21. Torma, T. Malignant tumors of the spine and the spinal extradural space: a study based on 250 histologically verified cases. Acta Chir. Scand. 1957 (Suppl. 225), 1-176.
22. Rathmell, J.P.; Roland, T.; DuPen, S.L. Management of pain associated with metastatic epidural spinal cord compression: use of imaging studies in planning epidural therapy. Reg. Anesth. Pain Med. 2000, 25, 113-116.
23. De Medicis, E.; de Leon-Casasola, O.A. Reversible paraplegia associated with lumbar epidural analgesia and thoracic vertebral metastasis. Anesth. Analg. 2001, 92, 1316-1318.
24. Hassenbusch, S.J.; Portenoy, R.K. Current practices in intraspinal therapy. A survery of clinical trends and decision making. J. Pain Symptom Manage. 2000, 20, S4-S11.
25. DuPen, S.L.; Kharasch, E.D.; Williams, A.R.; et al. Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain 1992, 49, 293-300.
26. Wallace, M.; Yaksh, T.L. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg. Anesth. Pain Med. 2000, 25, 117-157.
27. North, R.B.; Cutchis, P.N.; Epstein, J.A.; Long, D.M. Spinal cord compression complicating sub-arachnoid infusion of morphine: case report and laboratory experience. Neurosurgery 1991, 29, 778-784.
28. Aldrete, J.A.; Vascello, L.A.; Ghaly, R.; Tomlin, D. Paraplegia in a patient with an intrthecal catheter and a spinal cord stimulator. Anesthesiology 1994, 81, 1542-1545.
29. Blount, J.P.; Remley, K.B.; Yue, S.K.; Erickson, D.L. Intrathecal granuloma complicating chronic spinal infusion of morphine. J. Neurosurg. 1996, 84, 272-276.
30. Bejjani, G.K.; Karim, N.O.; Tzortzidis, F. Intrathecal granuloma after implantation of a morphine pump. Surg. Neurol. 1997, 48, 288-291.
31. Cabbell, K.L.; Taren, J.A.; Sagher, O. Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Neurosurgery 1998, 42, 1176-1180.
32. Langsam, A. A case of spinal cord compression syndrome by a fibrotic mass presenting in a patient with an intrathecal pain management pump system. Pain 1999, 83, 97-99.
33. Anderson, V.C.; Burchiel, K.J. A prospective study of long-term intrathecal morphine in the management of chronic mommalignant pain. Neurosurgery 1999, 44, 289-300.
34. Coffey, R.J.; Burchiel, K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 cases. Neurosurgery 2002, 50, 78-87.
35. Regional anesthetic techniques for the management of cancer pain. In Techniques in Regional Anesthesia and Pain Management; Urmey, W., Ed.; WB Saunders: Philadelphia, PA, 1997; Vol. 1, No. 1.
36. Rykowski, J.J.; Hilgier, M. Continuous celiac plexus block in acute pancreatitis. Reg. Anesth. 1995, 20, 528-532.
37. Ischia, S.; Ischia, A.; Polati, E.; et al. Three posterior percutaneous celiac plexus block techniques: a prospective randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992, 76, 534-540.
38. Singler, R.C. An improved technique for alcohol neurolysis of the celiac plexus block. Anesthesiology 1982, 56, 137-141.
39. Hilgier, M.; Rykowski, J.J. One needle transcrural celiac plexus block: single shot, or continuous technique, or both. Reg. Anesth. 1994, 19, 277-283.
40. Ischia, S.; Luzzani, A.; Ischia, A.; et al. A new approach to the neurolytic block of the coeliac plexus: the transaortic technique. Pain 1983, 16, 333-341.
41. Davis, D.D. Incidence of major complications of neurolytic coeliac plexus block. J. R. Soc. Med. 1993, 86, 264-266.
42. Wong, G.Y.; Brown, D.L. Celiac plexus block for cancer pain. In Techniques in Regional Anesthesia and Pain Management; Urmey, W, Ed.; WB Saunders: Philadelphia, PA, 1997; Vol. 1, No. 1.
43. Hanley, J.A.; Lippman-Hand, A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983, 249, 1743-1745.
44. Matson, J.A.; Ghia, J.N.; Levy, J.H. A case report of a potentially fatal complications associated with Ischia's transaortic method of celiac plexus block. Reg. Anesth. 1985, 10, 193-196.
45. Sett, S.S.; Taylor, D.C. Aortic pseudoaneurysm secondary to celiac plexus block. Ann. Vasc. Surg. 1991, 5, 88-91.
46. Kaplan, R.; Schiff-Keren, B.; Alt, E. Aortic dissection as a complication of celiac plexus block. Anesthesiology 1995, 83, 632-635.
47. Galizia, E.J.; Lahiri, S.K. Paraplegia following coeliac plexus block with phenol. Case report. Br. J. Anaesth. 1974, 46, 539-540.
48. Lo, J.N.; Buckley, J.J. Spinal cord ischemia a complication of celiac plexus block. Reg. Anesth. 1982, 7, 66-68.
49. Cherry, D.A.; Lamberty, J. Paraplegia following coeliac plexus block. Anaesth. Intensive Care 1984, 12, 59-61.
50. Woodham, M.J.; Hanna, M.H. Paraplegia after coeliac plexus block. Anaesthesia 1989, 44, 487-489.
51. van Dongen, R.T.; Crul, B.J. Paraplegia following coeliac plexus block. Anaesthesia 1991, 46, 862-863.
52. Jabbal, S.S.; Hunton, J. Reversible paraplegia following coeliac plexus block. Anaesthesia 1992, 47, 857-858.
53. Wong, G.Y.; Brown, D.L. Transient paraplegia following alcohol celiac plexus block. Reg. Anesth. 1995, 20, 352-355.
54. Brown, D.L.; Rorie, D.K. Altered reactivity of isolated segmental lumbar arteries of dogs following exposure to ethano and phenol. Pain 1994, 56, 139-143.
55. Mercadante, S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain 1993, 52, 187-192.
56. Ventafridda, G.V.; Caraceni, A.T.; Sbanotto, A.M.; et al. Pain treatment in cancer of the pancreas. Eur. J. Surg. Oncol. 1990, 16, 1-6.
57. Eisenberg, E.; Carr, D.B.; Chalmers, T.C. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth. Analg. 1995, 80, 290-295.
58. Yeager, M.P. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995, 83, 500-508.
59. Lillemoe, K.D.; Cameron, J.L.; Kaufman, H.S.; et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer: a prospective randomized trial. Ann. Surg. 1993, 217, 447-457.
60. Plancarte, R.; Amescua, C.; Patt, R.B.; et al. Superior hypogastric plexus block for pelvic cancer pain. Anesthesiology 1990, 73, 236-239.
61. de Leon-Casasola, O.A.; Kent, E.; Lema, M.J. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain 1993, 54, 145-151.
62. Plancarte, R.; de Leon-Casasola, O.A.; El-Helaly, M.; et al. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg. Anesth. 1997, 22, 562-568.
63. Rosenberg, S.K.; Tewari, R.; Boswell, M.V.; et al. Superior hypogastric plexus block successfully treats severe penile pain after transurethral resection of the prostate. Reg. Anesth. Pain Med. 1998, 23, 618-620.
64. Plancarte, R.; Amescua, C.; Patt, R.B. Presacral blockade of the ganglion of Walther (ganglion impar). Anesthesiology 1990, 73, A751.